This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vision-Sciences To Discuss EndoSheath(R) Technology On "Taking Stock With Pimm Fox"

ORANGEBURG, N.Y., March 17, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, is pleased to announce that Cheryl Pegus, M.D., President of Caluent, Director and Strategic Advisor of Glytec, and the Lead Independent Director of Vision-Sciences, will appear on a segment of the Bloomberg News TV show "Taking Stock with Pimm Fox" on Wednesday, March 19, 2014 during the 5:00 – 6:00 PM EDT hour.

"We are thrilled that Dr. Pegus will have the opportunity to discuss Vision Sciences' innovative Endosheath technology on Taking Stock with Pimm Fox," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences. "Our technology has become even more relevant in light of the recent focus on hospital-acquired infections and the steps the healthcare industry needs to take to help prevent these infections from developing."

Vision-Sciences' patented and FDA-cleared EndoSheath technology is the only flexible endoscopic technology on the market with a sterile, single-use barrier which prevents direct contact with the patient and reduces the difficulties of providing a sterile, patient ready device. In 20 years and with over 5 million procedures performed with EndoSheath technology, Vision-Sciences has never received a report of patient-to-patient cross-contamination.

Segment Details:

Date: Wednesday, March 19, 2014

Time:  5:00 – 6:00 PM EDT

Outlet:   Bloomberg News TV "Taking Stock with Pimm Fox"

For more information call Mitch Kayden at 845-709-5607 or email at

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath ® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at .

Vision-Sciences owns the trademark Vision Sciences™ and the registered trademarks EndoSheath ®, EndoWipe ®, Slide-On ®, and The Vision System ®.
CONTACT: Mitch Kayden
         Sr. Media Strategist
         Onit Digital Marketing
         (845) 709-5607
         Keith J. C. Darragh
         VP, Finance
         Vision-Sciences, Inc.
         (845) 365-0600

company logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.01 0.00%
FB $99.51 -0.24%
GOOG $677.65 -0.75%
TSLA $147.00 -0.67%
YHOO $26.82 -0.85%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs